Posted 2/15/2009 8:41 PM (GMT 0)
another study:
Visually directed HIFU for organ-confined
prostate cancer can produce a low PSA nadir
3 months after the procedure. In the present
patients, the mean PSA nadir was significantly
lower than that using an algorithm-based
protocol for treatment of similar patients,
and compares favourably with both
brachytherapy and cryotherapy for the
treatment of organ-confined prostate cancer
[15,16]. In the Seattle brachytherapy series
[17] 72% of patients with no evidence of
disease biochemically achieved PSA nadirs of
<
0.2 ng/mL, with the mean PSA nadir being
0.25 ng/mL. In the present study we achieved
PSA nadirs of
≤ 0.2 ng/mL in 84% of patients
using the visually directed method, and an
undetectable PSA level in just under a third of
those treated.
http://www.hifumx.com/docs/visually_directed_hifu_bju.pdf
~~~~~~~~~~~~~
I am not connected with the HIFU industry and (knock on wood) haven't yet, at age 70, experienced any serious prostate problems. As I mentioned earlier, the husband of a cyber-friend had his prostate cancer treated with the Sonablate 500 in Puerto Vallarta about 6 or 8 weeks ago, apparently successfully.